Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
6.45
-0.06 (-0.92%)
Mar 20, 2026, 3:00 PM CST
3.20% (1Y)
| Market Cap | 4.46B +2.1% |
| Revenue (ttm) | 2.27B -19.7% |
| Net Income | 222.85M +1.0% |
| EPS | 0.32 +4.8% |
| Shares Out | 692.00M |
| PE Ratio | 20.42 |
| Forward PE | n/a |
| Dividend | 0.40 (6.14%) |
| Ex-Dividend Date | Feb 6, 2026 |
| Volume | 8,986,101 |
| Average Volume | 9,990,205 |
| Open | 6.53 |
| Previous Close | 6.51 |
| Day's Range | 6.44 - 6.58 |
| 52-Week Range | 5.35 - 8.68 |
| Beta | 0.10 |
| RSI | 39.82 |
| Earnings Date | Apr 25, 2026 |